Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/19487069

Download in:

View as

General Info

PMID
19487069